Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9865145 | 0.78 | ALDH1A1 (0.66) | ALDH1A1CYP2A6HPGDALOX15HTT | |
| SCHEMBL13976240 | 0.73 | ALDH1A1 (0.42) | ALDH1A1CYP2A6 | |
| SCHEMBL12060697 | 0.72 | — | — | |
| SCHEMBL10742175 | 0.71 | ALDH1A1 (0.40) | ALDH1A1HPGDALOX15HTTHSD17B10 | |
| SCHEMBL19387443 | 0.67 | ALDH1A1 (0.47) | ALDH1A1HPGDALOX15HTTHSD17B10 | |
| SCHEMBL7836963 | 0.67 | KEAP1 (0.57) | ALDH1A1ALOX15 | |
| SCHEMBL8915615 | 0.64 | CYP2A6 (0.42) | ALDH1A1CYP2A6HPGDALOX15HTT | |
| SCHEMBL4175470 | 0.63 | KDM4E (0.50) | ALDH1A1HPGDALOX15HTTHSD17B10 | |
| SCHEMBL5839757 | 0.63 | KEAP1 (0.41) | ALDH1A1HPGDHSD17B10 | |
| SCHEMBL2306606 | 0.63 | ABCB1 (0.42) | ALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9771345-B2 | Coferons and methods of making and using them | CORNELL UNIVERSITY (US) | 2017-09-26 | — | — | US | disclosed |
| WO-2011043817-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2011-04-14 | — | — | WO | disclosed |